General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases. GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably. GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.